From time to time, The Cancer Letter's editors post Special Reports or other documents that may be of interest to its readers. All of these documents are free to download.

Current reports:

• Ortho vs. Amgen: Complaint
  
• Ortho vs. Amgen: Defendant's Memorandum
  
• FDA Oncology Drug Approvals from 2005-2008 (PowerPoint presentation).
  
• Transcript of NCI Board of Scientific Advisors discussion of ESA and Tumor Growth RFA concept.
  
• NCI RFA Concept on ESAs and Tumor Growth as presented to BSA on June 23, 2008.
  
• Report from NCI workshop on ESAs and Tumor Growth, Dec. 2007.
  
• NIH response to Dingell-Stupak letter on alleged conflicts in NLST.
  
• Sen. Grassley letter on conflicts in NIH extramural program, June 4, 2008.
  
• FDA's Professional Needs Budget sent to Sen. Arlen Specter May 5, 2008.
  
• FDA documents on Procrit direct-to-consumer advertising compiled by the Subcommittee on Oversight and Investigations of the House Committee on Energy & Commerce for a May 8, 2008, hearing.
  
• NSABP Response to NIH Rejection of P-4 Appeal.
  
• NIH Rejection of NSABP Appeal on P-4 Trial Cancellation.
  
• NSABP memo of March 26, 2008, on changes to informed consent policies.
  
• Indictment of Andrew Bodnar, former Bristol-Myers Squibb executive.
  
• Claudia Henschke's disclosure letter to American Cancer Society, Feb. 7, 2008.
  
• The NCI 2015 Goal (Special Report, August 2003)
  
• The National Dialogue on Cancer 2000-2002 (Special Report, August 2003)
  
• ImClone: The C225 Controversy (Special Report, March 2002)